Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,074.10
+1.20 (0.06%)
Jul 16, 2025, 3:29 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 157.33 billion as of July 16, 2025. Its market cap has increased by 40.20% in one year.
Market Cap
157.33B
Enterprise Value
149.46B
Revenue
19.37B
Ranking
n/a
PE Ratio
29.34
Stock Price
2,074.10
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 157.33B, an increase of 2,809,848.35%. That is a compound annual growth rate of 54.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,144.85B |
| Divi's Laboratories | 1,802.53B |
| Cipla | 1,204.28B |
| Mankind Pharma | 1,094.14B |
| Apollo Hospitals Enterprise | 1,058.33B |
| Zydus Lifesciences | 973.68B |
| Aurobindo Pharma | 669.08B |
| Glenmark Pharmaceuticals | 628.21B |